Navigation Links
NIH fellow uses computation, experimentation to study diabetes, obesity
Date:8/2/2011

221.10.254.64

Stephanie Nicole "Nikki" Lewis, a graduate student in the interdisciplinary doctoral program in genetics, bioinformatics, and computational biology at Virginia Tech, has been awarded the prestigious Ruth L. Kirschstein National Research Service Award for Predoctoral Research through the National Institutes of Health for her study of a cellular signaling receptor that is associated with chronic inflammatory diseases such as diabetes, obesity, and inflammatory bowel disease.

Lewis is applying a combination of computational modeling and experimental methods to identify molecules that can activate peroxisome proliferator activated receptor gamma (PPAR ), which is a therapeutic target for suppressing inflammation. The search for drugs targeting the receptor is urgently needed since use of current drugs to treat type II diabetes by binding to PPAR , like the recently restricted Avandia (GlaxoSmithKline), results in adverse side effects. A goal of Lewis' research is to identify novel, orally active naturally occurring compounds with therapeutic potential due to their insulin-sensitizing and anti-inflammatory actions. The computational methods are used to quickly and inexpensively screen large numbers of compounds, from which a small number are selected for experimental validation in vitro and through pre-clinical animal studies.

This project entitled "Virtual Screening Development to Complement Experimental Screening for PPAR Modulators to Treat Type II Diabetes Mellitus" is primarily funded through the National Institute of Diabetes and Digestive and Kidney Diseases of NIH.

Lewis is working jointly with David Bevan, professor of biochemistry in the College of Agriculture and Life Sciences, and Josep Bassaganya-Riera, associate professor in the Nutritional Immunology and Molecular Medicine Laboratory at the Virginia Bioinformatics Institute (www.modelingimmunity.org).

"The strength of Nikki's research lies not only in the combination of computational and experimental methods, but also in her approach that will unravel details of the events that accompany PPAR  activation, thereby making the drug discovery process more rational," Bevan said.

"Nikki's successful NIH proposal builds upon ongoing collaborative research between Dr. Bevan and NIMML aimed at streamlining the drug and nutraceutical discovery process. In addition, Nikki's project leverages and extends the scope of studies conducted by the Center for Modeling Immunity to Enteric Pathogens. Specifically, this effort is in line with the goal of discovering novel broad-based immune therapeutics for gastrointestinal infectious diseases by creating computational models of the mucosal immune system and sets the stage for multi-scale modeling in drug discovery," Bassaganya-Riera said.


'/>"/>

Contact: Lori Greiner
lgreiner@vt.edu
540-231-5863
Virginia Tech
Source:Eurekalert  

Related biology news :

1. Green light for EU co-funding of TUM Institute for Advanced Study fellowships
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
3. Entomological Society of America names 2011 fellows
4. Weatherstone Fellows publish research as Autism Speaks announces 2011 Weatherstone Fellows
5. Top Latin-American scientists named 2011 Pew Fellows in the Biomedical Sciences
6. Rensselaer scholar receives NSF Research Fellowship
7. ASPB awards 15 summer undergraduate research fellowships
8. OGI awards summer research fellowships to 7 Ontario students
9. 5 UH graduates receive NSF fellowships for further study
10. Top Australian malaria researcher elected Fellow of the Royal Society
11. Fellowship to UC Riverside botanist encourages Hispanic students to take up research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH fellow uses computation, experimentation to study diabetes, obesity
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology: